1933 Industries Announces First Quarter 2025 Financial Report
1933 Industries (OTC:TGIFF) reported its Q1 2025 financial results, showing mixed performance amid challenging market conditions in Nevada. The company generated revenue of $4.0 million, down from $5.2 million in Q1 2024, with the decline attributed to soft sales and falling flower prices across Nevada.
Key financial metrics include a gross profit of $1.3 million (vs $1.6 million in Q1 2024), improved gross margin of 33% (vs 31% in Q1 2024), and a net loss of $0.58 million (compared to $0.38 million loss in Q1 2024). Operating expenses decreased to $1.9 million from $2.0 million year-over-year.
The company's Alternative Medicine Association (AMA) brand achieved a notable #3 ranking among Nevada's most sold cannabis brands by volume, demonstrating resilience despite market price compression. Nevada's retail cannabis sales showed significant decline, falling 23% from $78 million in August to $59.8 million in September 2024.
1933 Industries (OTC:TGIFF) ha riportato i risultati finanziari del primo trimestre del 2025, mostrando una performance mista in un contesto di mercato difficile in Nevada. L'azienda ha generato entrate di 4,0 milioni di dollari, in calo rispetto ai 5,2 milioni di dollari del primo trimestre del 2024, con il declino attribuito a vendite deboli e al calo dei prezzi dei fiori in tutto il Nevada.
I principali indicatori finanziari includono un utile lordo di 1,3 milioni di dollari (rispetto a 1,6 milioni di dollari nel primo trimestre del 2024), un margine lordo migliorato del 33% (rispetto al 31% nel primo trimestre del 2024) e una perdita netta di 0,58 milioni di dollari (rispetto a una perdita di 0,38 milioni di dollari nel primo trimestre del 2024). Le spese operative sono diminuite a 1,9 milioni di dollari dai 2,0 milioni di dollari dell'anno precedente.
Il marchio dell'azienda, l'Alternative Medicine Association (AMA), ha raggiunto un notevole 3° posto tra i marchi di cannabis più venduti in Nevada per volume, dimostrando resilienza nonostante la compressione dei prezzi di mercato. Le vendite al dettaglio di cannabis in Nevada hanno mostrato un significativo calo, scendendo del 23% da 78 milioni di dollari ad agosto a 59,8 milioni di dollari a settembre 2024.
1933 Industries (OTC:TGIFF) informó sus resultados financieros del primer trimestre de 2025, mostrando un desempeño mixto en medio de condiciones de mercado desafiantes en Nevada. La compañía generó ingresos de 4,0 millones de dólares, una disminución respecto a los 5,2 millones de dólares en el primer trimestre de 2024, con la caída atribuida a ventas débiles y a la baja de precios de las flores en todo Nevada.
Los principales indicadores financieros incluyen una ganancia bruta de 1,3 millones de dólares (frente a 1,6 millones de dólares en el primer trimestre de 2024), un margen bruto mejorado del 33% (frente al 31% en el primer trimestre de 2024) y una pérdida neta de 0,58 millones de dólares (comparado con una pérdida de 0,38 millones de dólares en el primer trimestre de 2024). Los gastos operativos disminuyeron a 1,9 millones de dólares desde 2,0 millones de dólares en el año anterior.
La marca de la compañía, Alternative Medicine Association (AMA), logró un notable 3° lugar entre las marcas de cannabis más vendidas en Nevada por volumen, demostrando resiliencia a pesar de la compresión de precios del mercado. Las ventas de cannabis al por menor en Nevada mostraron una significativa disminución, cayendo un 23% de 78 millones de dólares en agosto a 59,8 millones de dólares en septiembre de 2024.
1933 Industries (OTC:TGIFF)는 2025년 1분기 재무 결과를 발표하며 네바다의 어려운 시장 환경 속에서 혼합된 성과를 보였습니다. 이 회사는 400만 달러의 수익을 기록했으며, 이는 2024년 1분기의 520만 달러에서 감소한 수치로, 감소는 부진한 판매와 네바다 전역의 꽃 가격 하락에 기인합니다.
주요 재무 지표로는 130만 달러의 총 이익 (2024년 1분기 160만 달러 대비), 개선된 총 마진 33% (2024년 1분기 31% 대비), 58만 달러의 순손실 (2024년 1분기 38만 달러 손실 대비)이 포함됩니다. 운영 비용은 작년 대비 200만 달러에서 190만 달러로 감소했습니다.
회사의 대체 의학 협회(AMA) 브랜드는 네바다에서 판매량 기준으로 3위를 기록하며 시장 가격 압박에도 불구하고 회복력을 보여주었습니다. 네바다의 소매 대마초 판매는 2024년 8월 7800만 달러에서 9월 5980만 달러로 23% 감소하는 등 큰 하락세를 보였습니다.
1933 Industries (OTC:TGIFF) a publié ses résultats financiers pour le premier trimestre de 2025, montrant une performance mitigée dans un contexte de marché difficile au Nevada. L'entreprise a généré des revenus de 4,0 millions de dollars, en baisse par rapport à 5,2 millions de dollars au premier trimestre de 2024, la baisse étant attribuée à des ventes faibles et à la chute des prix des fleurs dans tout le Nevada.
Les principaux indicateurs financiers incluent un bénéfice brut de 1,3 million de dollars (contre 1,6 million de dollars au premier trimestre de 2024), une marge brute améliorée de 33% (contre 31% au premier trimestre de 2024) et une perte nette de 0,58 million de dollars (comparée à une perte de 0,38 million de dollars au premier trimestre de 2024). Les dépenses d'exploitation ont diminué à 1,9 million de dollars contre 2,0 millions de dollars l'année précédente.
La marque de l'entreprise, l'Alternative Medicine Association (AMA), a atteint une 3ème place remarquable parmi les marques de cannabis les plus vendues au Nevada en volume, montrant une résilience malgré la compression des prix du marché. Les ventes de cannabis au détail au Nevada ont montré une baisse significative, passant de 78 millions de dollars en août à 59,8 millions de dollars en septembre 2024.
1933 Industries (OTC:TGIFF) hat seine Finanzzahlen für das erste Quartal 2025 veröffentlicht und zeigt eine gemischte Leistung in einem herausfordernden Marktumfeld in Nevada. Das Unternehmen erzielte Einnahmen von 4,0 Millionen Dollar, ein Rückgang von 5,2 Millionen Dollar im ersten Quartal 2024, wobei der Rückgang auf schwache Verkäufe und fallende Blumenpreise in Nevada zurückzuführen ist.
Wichtige Finanzkennzahlen umfassen einen Bruttogewinn von 1,3 Millionen Dollar (gegenüber 1,6 Millionen Dollar im ersten Quartal 2024), eine verbesserte Bruttomarge von 33% (gegenüber 31% im ersten Quartal 2024) und einen Nettoverlust von 0,58 Millionen Dollar (im Vergleich zu einem Verlust von 0,38 Millionen Dollar im ersten Quartal 2024). Die Betriebskosten sanken im Jahresvergleich von 2,0 Millionen Dollar auf 1,9 Millionen Dollar.
Die Marke des Unternehmens, die Alternative Medicine Association (AMA), erreichte einen bemerkenswerten 3. Platz unter den meistverkauften Cannabis-Marken in Nevada nach Volumen und zeigte damit Widerstandsfähigkeit trotz des Preisdrucks auf dem Markt. Die Einzelhandelsverkäufe von Cannabis in Nevada verzeichneten einen signifikanten Rückgang und fielen von 78 Millionen Dollar im August auf 59,8 Millionen Dollar im September 2024, was einem Rückgang von 23% entspricht.
- Improved gross margin to 33% from 31% YoY
- Achieved #3 ranking in Nevada cannabis brand sales by volume
- Reduced operating expenses to $1.9M from $2.0M YoY
- Revenue declined 23% YoY to $4.0M from $5.2M
- Gross profit decreased to $1.3M from $1.6M YoY
- Net loss increased to $0.58M from $0.38M YoY
- Market conditions deteriorating with Nevada sales dropping 23%
VANCOUVER, BC / ACCESS Newswire / February 27, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its first quarter financial results ("Q1 2025") for the three months ended October 31, 2024 and 2023. All amounts expressed are in Canadian dollars.
The Company owns
Highlights
Revenue of
$4.0 million Gross profit of
$1.3 million Gross margin of
33% Net loss of
$0.6 million 3rd Place ranking as one of the most sold cannabis brands in Nevada
Q1 2025 and Q1 2024 Consolidated Operating Financials
Revenue
The Company generated revenue of
Gross Profit
The Company generated gross profit of
Gross Margin
Gross margin calculated as gross profit divided by revenue was
Expenses
During the reporting period, expenses decreased to
Net Loss
Net loss for the period was
Management Commentary
Slower retail sales across Nevada impacted the Company's total revenue and gross profit as compared to Q1 2024. Despite the retail slowdown in the cannabis market, the Company made gains in gross margin as it continues to run a more efficient operation and improves its cannabis production. Against price compression in the state, the AMA brand has demonstrated resilience in a competitive landscape and ranked #3 as one of the most sold brand in Nevada by volume2.
Financial statements are prepared in accordance with International Financial Reporting Standards. Detailed information regarding the Company's financial results as well as management's discussion and analysis can be found at https://sedar.com/ and https://1933industries.com/investors/financial-information
1 https://tax.nv.gov/wp-content/uploads/2024/12/NV-Cannabis-Revenue-FY25.pdf
2 https://www.headset.io/brands/alternative-medicine-association-ama
About 1933 Industries Inc.
1933 Industries is a Nevada-based licensed producer, focused on the cultivation and extraction of a large portfolio of cannabis consumer products in a variety of formats under its flagship brands, Alternative Medicine Association (AMA) and Level X. Its product offerings are cultivated at the Company's 68,000 sq. ft. indoor facility and marketed directly to retail dispensaries. AMA branded flower, infused pre-rolls, and in-house boutique concentrates consistently rank as the top products sold in Nevada. For more information, please visit www.1933industries.com
For further information please contact:
Alexia Helgason, VP, Investor Relations
604-728-4407
alexia@1933industries.com
Brian Farrell, Chairman and CEO
brian@1933industries.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on www.sedar.com. 1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.
SOURCE: 1933 Industries Inc.
View the original press release on ACCESS Newswire
FAQ
What was TGIFF's revenue and profit for Q1 2025?
How did TGIFF's Q1 2025 performance compare to Q1 2024?
What caused TGIFF's revenue decline in Q1 2025?
What is TGIFF's market position in Nevada?
